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1. Introduction  
Cardiovascular diseases remain the leading cause of morality in the western world. The aim 
of this chapter is to understand the pathogenesis of acute coronary syndromes from 
atherosclerotic plaque formation, to plaque progression and vascular remodeling, to plaque 
destabilization, to ultimately plaque rupture or erosion and thrombus formation.  
A cascade of interacting factors leads to plaque formation, progression, fraglisation, and 
rupture. 
Features associated with plaque rupture are: large eccentric soft lipid core, thin fibrous cap, 
inflammation in the cap and adventitia, increased plaque neovascularity, and outward or 
positive vessel remodeling. 
Vasospasm is a separate mechanism for developing ACS without plaque rupture or erosion 
will not be discussed in this chapter. 
2. Atherosclerosis 
Atherosclerosis is a chronic disease that can remain asymptomatic through decades. It is 
enhanced by modifiable and non modifiable risk factors and consists of intra intimal 
accumulation of intra cellular and extracellular oxidized LDL, macrophages, T cells, smooth 
muscle cells, proteoglycan, collagen, calcium, and necrotic debris. Low endothelial shear 
stress can contribute to atherosclerotic plaque formation, vulnerabilisation, and rupture. 
Intimal accumulation of oxidized LDL-C, called fatty streaks constitutes the earliest 
histopathologic stage of atherosclerosis. 
Adhesion molecules expressed by endothelial cells mediate the rolling and adhesion of 
circulating leukocytes on the endothelial surface. Chemoattractant chemokines promote 
transmigration of leukocytes into the intima. Monocytes infiltrate beneath the endothelium, 
differentiate to macrophages, phagocytose the oxidized LDL-C and transform into foam 
cells. Foam cells produce cytokines, growth factors, reactive oxygen species and matrix-
degrading enzymes, sustaining atherosclerosis progression. The intensity of oxidized LDL-C 
accumulation in the subendothelial space is a major stimulus for the ongoing inflammatory 
process. The accumulation of lipid-laden foam cells constitute the intermediate lesions or 
pathologic intimal thickening, which evolve through several stages of progression.  
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3. Arterial remodeling 
Arterial remodeling involves a cascade of structural and morphological changes of a vessel 
wall in response to various stimuli including changes in blood flow and pressure, and acute 
injury; all three are common findings in atherosclerotic plaques.  
Two types of coronary arterial remodeling have been described: 
- Negative remodeling: defined as local shrinkage, negative remodeling is more often 
seen in patients with stable angina and is associated with smaller plaque areas. It might 
be seen in arterial wall healing after injuries such as balloon injury, that could be mainly 
related to vascular wall contracture and consequent luminal narrowing. The biological 
events involved in this wound healing involve complex series of interacting growth 
factors, integrins and proteases.  
- Positive or outward remodeling:  defined by a compensatory increase in local vessel 
size in response to increasing plaque burden minimizing the degree of luminal stenosis. 
Positive remodeling characterizes unstable vulnerable plaques.  
There are studies demonstrating that plaque rupture occurs in insignificant, mildly 
occlusive plaques, this could be explained by positive remodeling: the increase in total 
arterial area that accompanies plaque accumulation. Large positive remodeled plaques 
while paradoxically protecting against luminal narrowing, are more susceptible to 
mechanical forces that lead to plaque rupture and an unstable clinical presentation.  
The pathogenesis of arterial remodeling is not fully understood and remains debated. Many 
hypotheses have been advanced.  
Arterial wall neovascularisation of atherosclerotic plaques seems to have a potential role in 
modulating lesion formation and structural changes of the arterial wall, by nourishing the 
growing plaque. Various angiogenic growth factors and receptors are implicated in 
coronary wall angiogenesis such as   VEGF/VPF, estrogen, interleukin 8, bFGF, and aFGF; 
the role of TNF-ǂ and TGF-ǃ remains controversial. 
Angiotensine II via AT1 receptors is another trigger of plaque neovascularisation and 
remodeling. 
Activation of NADPH oxidase by various triggers such as Angiotensine II and mechanical 
stretch promotes ROS production and ROS-mediated pathways leading to vascular remodeling.  
In addition Low ESS leads to inflammation of the wall beneath the plaque and shift of the 
extracellular matrix balance toward degradation. Within such an environment the internal 
elastic lamina undergoes severe fragmentation, and the atherosclerotic process extends into 
the media degrading the collagen and elastin fibers, thereby promoting arterial expansion 
and outward remodeling. 
Human studies using intravascular ultrasound confirmed that outward or positive 
remodeling is more common at culprit lesion sites in patients with unstable angina, whereas 
inward or negative remodeling is more common in patients with stable angina.  
 
Pathogenesis of positive arterial remodeling 




Table 1. This table summarizes factors contributing to positive plaque remodeling that is 
associated with unstable plaque. 
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4. Plaque destabilisation 
Typically a vulnerable plaque is described as having a thin fibrous cap and a rich superficial 
lipid core. Weakening of the fibrous cap is due mainly to accelerated degradation of 
collagen and other matrix components.  
Many factors contribute to plaque vulnerabilisation: 
4.1 Inflammation 
Inflammation cells such as activated monocytes and macrophages and, to a lesser degree, T 
cells play a crucial role in destabilizing the fibrous cap tissue and, therefore, enhance the risk 
of plaque rupture.  
Adhesion molecules such as VCAM-1 as well as chemokines such as MCP-1 recruite 
inflammatory cells into the atherosclerotic plaques. Inflammatory cells are activated in the 
vessel wall by oxidized lipids and cytokines such as M-CSF. 
Adventitial neovasculature also enhances inflammatory cells entry and recruitement inside 
the atherosclerotic lesion.  
Many mediators secreted by plaque macrophages could be involved in fibrous cap 
weakening including: 
- Interleukin (IL)-18: also called interferon gamma-inducing factor, is a proinflammatory 
cytokine secreted by plaque macrophages. Increased serum IL-18 may be an 
independent predictor of cardiovascular mortality.  
- Matrix Metalloproteinases (MMP): mainly MMP-2 (Gelatinse A), MMP-9 (Gelatinase B), 
and MMP-8 (Collagenase), released from activated macrophage foam cells, directly 
mediate matrix degradation of the plaque fibrous cap. Oxidized LDL containing 
arachidonic and linoleic acid  upregulates the expression of metalloproteinase, while 
HDL reverses this effect. 
- Tissue factor: expressed by macrophages is the main initiator of thrombogenesis.  
Inflammation usually concerns the entire coronary circulation not only the culprit lesion. 
This fact explains why patients with acute coronary syndrome may have multiple 
vulnerable plaques. 
 
Mechanisms of Angiotensine II mediated plaque weakening  
Upregulation of IL6 gene 
Upregulation of MMP genes 
Activation of mitogen-activated protein kinase cascades 
Activation of tyrosine kinases 
Stimulation of neovascularisation  
Table 2. This table summarizes the leading mechanisms of Angiotensine II mediated 
atherosclerotic plaque weakening 
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4.2 Renin-angiotensin system 
There is evidence of angiotensin converting enzyme (ACE), angiotensine II, and AT1 
receptors within the plaque.  An increased activity of ACE was found within culprits lesions 
in the setting of acute coronary syndromes, probably related to a local secretion. 
Angiotensine II increases the likelihood of  plaque progression and rupture via AT1 
receptors by regulating the gene expression of various bioactive substances mainly 
interleukine 6  (IL6), metalloproteinases, and other growth factors and cytokines. 
Angiotensine II also activates multiple intracellular signaling cascades (mitogen-activated 
protein kinase cascades, tyrosine kinases, and various transcription factors) in coronary 
endothelial and smooth muscle cells. 
In addition Angiotensine II enhances plaque neovascularisation.  
4.3 Hemodynamical factors mainly shear stress 
4.3.1 Definitions  
- Endothelial shear stress (ESS): tangential force derived by the friction of the flowing 
blood on the endothelial surface. It is the product of the shear rateat the wall and the 
blood viscosity. 
- Shear rate: The spatial gradient of blood velocity from areas at the arterial wall toward 
areas at the center of the lumen (dv/dy, where dv is change in flow velocity and dy is 
change in radial distance from the wall). 
Physiologically, the shear rate decreases at the center of the lumen and gradually 
increases toward the wall. 
- Blood viscosity: A principal property of blood related to its internal friction that causes 
blood to resist flow. Hematocrit is the major determinant of blood viscosity. 
Although the entire vasculature is exposed to the atherogenic effects of the systemic risk 
factors such as hyperlipidemia, cigarette smoking, hypertension, diabetes mellitus, and 
genetic predisposition, atherosclerotic lesions form at specific regions of the arterial tree, 
such as in the vicinity of branch points, the outer wall of bifurcations, and the inner wall of 
curvatures, where disturbed flow occurs and ESS is low. 
Low ESS induces endothelial dysfunction by reducing the bioavailability of nitric oxid via a 
decrease in eNOS messenger ribonucleic acid and protein expression, thereby exposing the 
endothelium to the atherogenic effect of local and systemic risk factors. Nitric oxide is a key 
component of normal vascular tone, characterized by strong anti-inflammatory, 
antiapoptotic, anti-mitogenic, and anti-thrombotic properties. In addition, low ESS 
downregulates prostacyclin, another endothelial vasodilatory substance and upregulates 
endothelin-1,  a potent vasoconstrictive and mitogenic molecule.  
Low ESS also promotes subendothelial deposition and accumulation of LDL-C by increasing 
mitotic and apoptotic activity of endothelial cells and inducing conformational changes of 
endothelial cells from fusiform to polygonal shape, widening thereby the junctions between 
endothelial cells.  
Gene expression as well as post-transcriptional activity of the major oxidative enzymes at 
endothelial cell membranes are enhanced by low ESS, leading to the production of reactive 
oxygen species within the intima. 
In addition gene expression of several adhesion molecules, chemoattractant chemokines and 
proinflammatory cytokines are upregulated by low ESS. 
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Mechanisms of low ESS mediated plaque weakening 
Endothelial dysfunction: 
 Decreases eNOS 
 Downregulates Prostacycline synthesis  
 Upregulates Endotheline-1 synthesis  
LDL-C  sub-intimal uptake and accumulation 
Promotes inflammation  
Promotes oxidative stress 
Table 3. This table summarizes the contribution of low ESS to plaque weakening.  
4.4 Strenuous exercise  
Strenuous exercise especially among those who exercise infrequently and have multiple 
cardiac risk factors, is associated with increased temporary risk of plaque rupture and 
myocardial infarction via increase wall stress due to rapid increase in heart rate and blood 
pressure, coronary vasospasm, increased flexing of epicardial coronary arteries, deepening 
of existing plaque fissures, and catecholamine induced platelet aggregation.   
4.5 In vivo detection of vulnerable plaque with optical coherence tomography 
Optical coherence tomography (OCT) is recently developed imaging modality, using infra 
red light and characterized by the higher existing resolution (axial resolution: 10-15μm) 
allowing a microscopical description of the atherosclerotic plaque in vivo within the 
coronary arteries. OCT is validated for the detection of vulnerable plaque wich is typically 
characterized by: 
- Thin fibrous cap < 65 μm 
- Rich lipid core: when lipid is present within two or more quadrants of the plaque. 
- Microchannels in case of plaque neovascularisation.   
 
 
Fig. 1. Fibrous cap assessment with OCT: fibrous cap is a signal rich layer separating the lumen 
from the signal poor underlying lipid core. Fibrous cap is measured at its thinest segment. 
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Fig. 2. OCT showing a thick fibrous cap, calcified plaque. Calcium is seen as a homogeneous 





Fig. 3. OCT showing a lipid rich plaque. Lipid is seen as a heterogeneous signal poor region 
with irregular edges. 
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Fig. 4. Adventicial and subintimal increazed neovascularization characterizes unstable 
plaque and can be detected in vivo with OCT. Neovessels or microchannels are seen as no-
signal tubulo-luminal structure without a connection to the vessel lumen and recognized on 
≥ 3 consecutive cross sectional OCT images. 
5. Plaque rupture 
As previously explained the fibrous cap rupture results from an imbalance between 
synthesis and breakdown of extracellular matrix collagen and other matrix components 
leading to thinning of the cap, predisposing the cap to spontaneous rupture or rupture in 
response to a variety of triggers. Plaque rupture primarily occurs in yellowish plaques with 
an increased lipid core and thin fibrous cap. Rupture of the thin fibrous cap exposes blood 
flow to the lipid core. The lipid core is believed to be highly thrombogenic when exposed to 
circulating blood. The enhanced thrombogenicity of the lipid core has been attributed to the 
high levels of functionally active tissue factor most likely derived from the death of 
macrophages inside the plaque. In addition to tissue factor, oxidized lipids in the lipid core 
may also directly stimulate platelet aggregation. 
The thrombus is usually occlusive in STEMI and nonocclusive in NSTEMI.  Episodes of 
plaque disruption and thrombosis may be subclinical and do not always result in acute 
coronary syndrome. Healing process may play an integral role in the progression of 
atherosclerosis, having the potential to cause sudden plaque growth.  
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Fig. 5. (A)- Coronary angiogram showing ostial occlusion (TIMI 0 flow) of the left ascending 
artery responsible of acute STEMI; (B)- OCT performed in the same patient after thrombo-
aspiration and restauration of a TIMI 3 flow, shows the site of plaque rupture, defined  by a 







Fig. 6. Rupture site detected with OCT (right) in the setting of NSTEMI. The coronary 
angiogram (left) shows a subocclusion of the segment 2 of the right coronary artery. 
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Fig. 7. (A)- Coronary angiogram showing occlusion of the segment 1 of right coronary artery 
in a patient presenting with STEMI; (B)- OCT performed after thrombo-aspiration showed 






Fig. 8. Red thrombus in the setting of ACS is seen with OCT as hypersignal  protusion 
within the lumen, however, unlike white thrombus, red thrombus is characterised by a 
signal attenuation  and posterior signal free shadowing due to the backscatering properties 
of the red blood cells wich are highly present in red thrombus. 
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6. Plaque erosion 
Plaque erosion usually occurs in younger patients, women and smokers.  
Culprit lesion do not have a large lipid core but instead have a proteoglycan-rich matrix, a 
deep lipid core, the prevalence of inflammation is lower with less macrophages and T cells 
and more smooth muscle cells compared to culprit lesions in plaque ruptures. Plaque 
erosion is defined as acute thrombus in direct contact with the intimal plaque without 
rupture of a lipid pool. The plaque luminal surface is irregular and eroded. 
Thrombus resulting from plaque erosion has been reported to be 20% to 40% of all coronary 
thrombi. The precise mechanisms of thrombosis in this entity are not known.  
Thrombosis in such cases might be triggered by an enhanced systemic thrombogenic state 
such as enhanced platelet aggregability, increased circulating tissue factor levels, and 
depressed fibrinolytic state. In addition activated circulating leucocytes may transfer active 
tissue factor by shedding microparticles and transferring them onto adherent platelets.  
Virmani et al have also identified yet another pathological variant where a calcified nodule 
within the plaque erodes through the surface of the plaque leading to thrombosis.  
7. Abbreaviations 
ACS Acute coronary syndrome 
LDL-C Low density lipoprotein cholesterol  
ESS Endothelial shear stress 
VEGF Vascular endothelial growth factor  
VPF Vascular permeability factor  
FGF Fibroblast growth factor  
TNF   Tumor necrosis factor  
TGF Transforming growth factor  
AT1 Angiotensine  type 1 
IL Interleukine  
MMP Matrix  metalloproteinase 
NADPH Nicotinamide Adenosine Dinucleotide Phosphate 
VCAM Vascular cellular adhesion molecule 
ROS Reactive oxygen species 
MCP Monocyte Chemotactic Protein 
CSF Colony stimulating factor  
ACE Angiotensine converting enzyme 
HDL High density lipoprotein 
eNOS Endothelial nitric oxide synthase  
OCT Optical coherence tomography 
TIMI Thrombolysis In Myocardial Infarction 
STEMI ST elevation myocardial infarction  
NSTEMI Non ST elevation myocardial infarction 
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